Cancer and Oncology Terms

A type of gene that makes a protein called a tumor suppressor protein that helps control cell growth.

A substance that has been studied in the treatment of cancer and is being studied in the treatment of rheumatoid arthritis and certain skin conditions.

A substance being studied in the treatment of head and neck cancer.

A drug used to treat prostate cancer that has spread.

APL is an aggressive subtype of acute myeloid leukemia marked by a specific chromosomal rearrangement and treated differently from other forms.

A substance that is being studied in the treatment of cancer.

A cell protein that can attach to certain molecules in some cancer cells and may kill the cells.

The name points at a microscope pattern, not at the lungs: cell clusters walled off by fibrous bands.

A rare type of ovarian tumor in which the tumor cells secrete a male sex hormone.

An astrocytoma is a brain or spinal cord tumor originating from astrocytes, star shaped cells that support and nourish neurons.

An aggressive cancer of the central nervous system, kidney, or liver that occurs in very young children.

A substance being studied in the treatment of some types of cancer.

A substance being studied in the treatment of some types of cancer.

A rare, inherited, progressive, degenerative disease of childhood that causes loss of muscle control, a weakened immune system, and an increased risk of cancer.

An aggressive (fast-growing) type of T-cell non-Hodgkin lymphoma caused by the human T-cell leukemia virus type 1 (HTLV-1).

A substance being studied in the treatment of cancer.

Atrasentan is an endothelin receptor antagonist now approved to reduce protein loss in the urine caused by a form of kidney disease.

An aggressive cancer of the central nervous system, kidney, or liver that occurs in very young children.

A benign (not cancer) condition in which there are more cells than normal in the lining of breast ducts and the cells look abnormal under a microscope.

Atypical ductal hyperplasia is a benign breast condition marked by abnormal appearing cells that raises the future risk of breast cancer.